Aricept has been a very effective blockbuster for the group as a whole and the loss of exclusivity affects not only France but entire company. How…
In Conversation
There is a lot of change occurring in the French pharmaceutical industry at the moment and this is no different for Boehringer Ingelheim. Just last September…
As president of LEEM, what will be your legacy and what legacy would you like to instill in the organization? A legacy of re-industrialization in the…
Recordati was created in 1926, and the combined work of three generations turned the small laboratory not only into a local success story but also a…
The acquisition of Jerini has to be one of the biggest milestones for Shire Deutschland in its recent history. How have the synergies developed between the…
You arrived at Grünenthal fairly recently, in January of this year. What was it about the company that attracted you to the position? That goes back…
Roche has a long history in France and currently enjoys a higher position than its worldwide ranking. Can you elaborate on the importance of this market…
Do you feel the industry has changed more over the past ten years than over the entire 40 years before? It’s an optical illusion. People always…
As the G5 brings together five very different companies – Ipsen, LFB, Pierre Fabre, Sanofi-Aventis, Servier – could you explain the origin behind the creation and…
You’ve been at the head of AstraZeneca France for 7 years through during which time there has been a lot of M&A activity in the industry…
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within…
Your father was the founder of Dr. Franz Köhler Chemie – that carries his name – and was a very well respected doctor among the German…
